TY - JOUR
T1 - An anxiolytic role for CRF receptor type 1 in the globus pallidus
AU - Sztainberg, Yehezkel
AU - Kuperman, Yael
AU - Justice, Nicholas
AU - Chen, Alon
N1 - European Research Council [260463]; Israel Science Foundation; Legacy Heritage Biomedical Science Partnership; Israel Ministry of Health; Nella and Leon Benoziyo Center for NeurosciencesThis work was supported by an FP7 Grant from the European Research Council (#260463); a research grant from the Israel Science Foundation; a research grant from Roberto and Renata Ruhman; a research grant from the Legacy Heritage Biomedical Science Partnership; a research grant from the Israel Ministry of Health; a grant from Mr. and Mrs. Mike Kahn; a research grant from Jorge David Ashkenazi, a research grant from Mr. and Mrs. Barry Wolfe; and a research grant from Nella and Leon Benoziyo Center for Neurosciences. We thank S. Ovadia for his devoted assistance with animal care. We thank Dr. D. E. Grigoriadis (Neurocrine Biosciences, San Diego, CA) for providing the CRFR1 antagonist NBI 30775. A. C. is the incumbent of the Philip Harris and Gerald Ronson Career Development Chair.
PY - 2011/11/30
Y1 - 2011/11/30
N2 - Corticotropin-releasing factor receptor type 1 (CRFR1) plays a major role in the regulation of neuroendocrine and behavioral responses to stress and is considered a key mediator of anxiety behavior. The globus pallidus external (GPe), a main relay center within the basal ganglia that is primarily associated with motor and associative functions, is one of the brain nuclei with the highest levels of CRFR1 expression in the rodent brain. However, the role of CRFR1 in the GPe is yet unknown. In the present study, we used a lentiviral-based system of RNA interference to show that knockdown of CRFR1 mRNA expression in the GPe of adult mice induces a significant increase in anxiety-like behavior, as revealed by the light-dark transfer, open-field, and elevated plus-maze tests. This effect was further confirmed by pharmacological administration of the selective CRFR1 antagonist NBI 30775 (1.75 μg/side) directly into the GPe. In the marble-burying test, blockade of CRFR1 in the GPe increased the percentage of marbles buried and the duration of burying behavior. Additionally, we present evidence suggesting that the enkephalin system is involved in the effect of GPe-CRFR1 on anxiety-like behavior. In contrast to the well established anxiogenic role of CRFR1 in the extended amygdala, our data reveal a novel anxiolytic role for CRFR1 in the GPe.
AB - Corticotropin-releasing factor receptor type 1 (CRFR1) plays a major role in the regulation of neuroendocrine and behavioral responses to stress and is considered a key mediator of anxiety behavior. The globus pallidus external (GPe), a main relay center within the basal ganglia that is primarily associated with motor and associative functions, is one of the brain nuclei with the highest levels of CRFR1 expression in the rodent brain. However, the role of CRFR1 in the GPe is yet unknown. In the present study, we used a lentiviral-based system of RNA interference to show that knockdown of CRFR1 mRNA expression in the GPe of adult mice induces a significant increase in anxiety-like behavior, as revealed by the light-dark transfer, open-field, and elevated plus-maze tests. This effect was further confirmed by pharmacological administration of the selective CRFR1 antagonist NBI 30775 (1.75 μg/side) directly into the GPe. In the marble-burying test, blockade of CRFR1 in the GPe increased the percentage of marbles buried and the duration of burying behavior. Additionally, we present evidence suggesting that the enkephalin system is involved in the effect of GPe-CRFR1 on anxiety-like behavior. In contrast to the well established anxiogenic role of CRFR1 in the extended amygdala, our data reveal a novel anxiolytic role for CRFR1 in the GPe.
UR - http://www.scopus.com/inward/record.url?scp=82555174685&partnerID=8YFLogxK
U2 - https://doi.org/10.1523/JNEUROSCI.3087-11.2011
DO - https://doi.org/10.1523/JNEUROSCI.3087-11.2011
M3 - مقالة
SN - 0270-6474
VL - 31
SP - 17416
EP - 17424
JO - Journal of Neuroscience
JF - Journal of Neuroscience
IS - 48
ER -